PharmaCielo Ltd.
PCLO.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 43.57% | 127.22% | 48.09% | 50.03% | 7.83% |
| Total Depreciation and Amortization | 105.99% | 52.35% | -66.25% | -94.23% | 332.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -773.57% | -77.15% | -36.48% | -32.43% | -44.91% |
| Change in Net Operating Assets | -96.68% | -3,712.04% | -46,664.15% | 934.46% | -0.52% |
| Cash from Operations | -1,048.20% | 377.28% | -532.39% | 445.85% | 25.08% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -24.92% |
| Cash from Investing | 10,437.99% | -- | -- | -- | -24.92% |
| Total Debt Issued | -71.60% | -71.04% | -95.88% | -85.43% | 28.57% |
| Total Debt Repaid | 100.00% | 151.18% | -5,280.50% | -492.20% | -44.95% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -62.44% | -20.60% | -769.73% | -552.70% | -39.49% |
| Foreign Exchange rate Adjustments | -242.19% | 188.89% | 1,783.33% | 54.55% | 137.04% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,328.93% | -73.29% | 1,828.57% | 65.77% | -81.36% |